APGE
NASDAQ · Biotechnology
Apogee Therapeutics Inc
$135.07
-0.01 (-0.01%)
Performance
1D
—
1W
—
1M
—
3M
+0.00%
6M
+60.91%
1Y
+137.92%
YTD
+78.24%
Open$135.08
Previous Close$135.08
Day High$135.09
Day Low$135.06
52W High$135.09
52W Low$52.34
Volume—
Avg Volume1.54M
Market Cap10.22B
P/E Ratio—
EPS$-4.34
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$84.66
Above
SMA 200
$67.12
Above
RSI (14)
81.2
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Hold
21 analysts
Price Target
-24.8% upside
Current
$135.07
$135.07
Target
$101.57
$101.57
$78.76
$101.57 avg
$153.22
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 911.35M | 871.62M | 948.06M |
| Net Income | -243,438,723 | -174,175,180 | -203,637,440 |
| Profit Margin | -26.7% | -20.0% | -21.5% |
| EBITDA | -267,934,128 | -228,786,100 | -261,593,713 |
| Free Cash Flow | -101,879,133 | -97,401,406 | -128,866,616 |
| Rev Growth | +22.2% | +5.3% | +12.3% |
| Debt/Equity | 0.88 | 0.85 | 0.60 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $293.30 | +0.68% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $463.45 | +0.66% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $169.25 | +1.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $549.39 | +0.42% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $922.99 | +2.06% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.52 | +0.37% | 7.7 | 20.98B |